Instil Bio, Inc. (TIL)
USD 19.6
(-9.64%)
USD 19.6
(-9.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -82.02 Million | -180.16 Million | -122.13 Million | -29.61 Million | -5.29 Million |
| Net Income | -156.08 Million | -223.17 Million | -156.79 Million | -37.73 Million | -6.52 Million |
| Depreciation & Amortization | 4.75 Million | 5.98 Million | 2.75 Million | 256 Thousand | 20 Thousand |
| Deferred income taxes | 1.12 Million | - | 710 Thousand | -643 Thousand | - |
| Stock-based compensation | 18.16 Million | 30.44 Million | 26.19 Million | 1.7 Million | 293 Thousand |
| Change in working capital | -9.01 Million | -9.56 Million | 4.36 Million | 1.47 Million | 366 Thousand |
| Other non-cash items | 59.02 Million | 16.15 Million | 636 Thousand | 5.32 Million | 550 Thousand |
| Investing Cash Flow | 41.12 Million | 114.54 Million | -474.39 Million | -51.12 Million | -760 Thousand |
| Investments in PPE | -20.66 Million | -84.58 Million | -57.83 Million | -50.81 Million | -760 Thousand |
| Acquisitions | - | 1.17 Million | - | -306 Thousand | - |
| Investment purchases | -301.46 Million | -666.22 Million | -1.1 Billion | - | - |
| Sales/Maturities of investments | 361.7 Million | 865.35 Million | 691 Million | - | - |
| Other Investing Activities | 1.55 Million | -1.17 Million | - | - | -550 Thousand |
| Financing Cash Flow | 8.08 Million | 71.88 Million | 393.16 Million | 313.04 Million | 14.94 Million |
| Debt repayment | -8.08 Million | -70.33 Million | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 1.54 Million | 393.23 Million | 312.98 Million | 14.94 Million |
| Other Financing Activities | 8.08 Million | 140.67 Million | -69 Thousand | 65 Thousand | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -1.12 Million | -1.8 Million | 3.86 Million | -1.05 Million | 309 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -7.88 Million | -7.76 Million | 499 Thousand | 2.52 Million | 57 Thousand |
| Cash at beginning of period | 43.71 Million | 38.09 Million | 241.76 Million | 8.89 Million | - |
| Cash at end of period | 10.69 Million | 43.71 Million | 38.09 Million | 241.76 Million | 8.89 Million |
| Capital Expenditure | -20.66 Million | -84.58 Million | -57.83 Million | -50.81 Million | -760 Thousand |
| Effect of forex changes on cash | -201 Thousand | -637 Thousand | -304 Thousand | 559 Thousand | - |
| Net cash flow / Change in cash | -33.02 Million | 5.62 Million | -203.67 Million | 232.86 Million | 8.89 Million |
| Free Cash Flow | -102.69 Million | -264.75 Million | -179.96 Million | -80.43 Million | -6.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.91 Million | -24.3 Million | -12.92 Million | -156.08 Million | -67.43 Million | -18.66 Million |
| Depreciation & Amortization | 1 Million | 993 Thousand | 1.03 Million | 4.75 Million | 953 Thousand | 991 Thousand |
| Deferred income taxes | - | - | -7.1 Million | 1.12 Million | 45.48 Million | -2.24 Million |
| Stock-based compensation | 4.17 Million | 4.51 Million | 4.55 Million | 18.16 Million | 4.67 Million | 4.41 Million |
| Change in working capital | -1.02 Million | 1.82 Million | -1.05 Million | -9.01 Million | 1.23 Million | -5.38 Million |
| Other non-cash items | 6.33 Million | 9.06 Million | 2.1 Million | 59.02 Million | 668 Thousand | 1.32 Million |
| Investing Cash Flow | 11.91 Million | 9.24 Million | 13.95 Million | 41.12 Million | 2.31 Million | 10.33 Million |
| Investments in PPE | - | - | -58 Thousand | -20.66 Million | -5.15 Million | -6.98 Million |
| Acquisitions | 541 Thousand | - | - | - | - | - |
| Investment purchases | -40.42 Million | -50.65 Million | -50.94 Million | -301.46 Million | -72.02 Million | -96.48 Million |
| Sales/Maturities of investments | 51.8 Million | 59.9 Million | 63.4 Million | 361.7 Million | 79.5 Million | 113.8 Million |
| Other Investing Activities | 541 Thousand | - | 1.55 Million | 1.55 Million | - | - |
| Financing Cash Flow | - | - | 1.01 Million | 8.08 Million | -587 Thousand | 4.2 Million |
| Debt repayment | - | - | -587 Thousand | -8.08 Million | -587 Thousand | -4.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 587 Thousand | 8.08 Million | -587 Thousand | 8.4 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -9000.00 | 20 Thousand | -477 Thousand | -1.12 Million | -425 Thousand | 753 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.01 Million | 1.8 Million | -574 Thousand | -7.88 Million | 1.65 Million | -6.13 Million |
| Cash at beginning of period | 5.48 Million | 10.69 Million | 9.13 Million | 43.71 Million | 22.92 Million | 28.02 Million |
| Cash at end of period | 6.78 Million | 5.48 Million | 10.69 Million | 10.69 Million | 10.14 Million | 22.92 Million |
| Capital Expenditure | - | - | -58 Thousand | -20.66 Million | -5.15 Million | -6.98 Million |
| Effect of forex changes on cash | -8000.00 | -63 Thousand | -19 Thousand | -201 Thousand | -85 Thousand | -73 Thousand |
| Net cash flow / Change in cash | 1.29 Million | -5.21 Million | 1.56 Million | -33.02 Million | -12.77 Million | -5.1 Million |
| Free Cash Flow | -10.61 Million | -14.39 Million | -13.43 Million | -102.69 Million | -19.58 Million | -26.54 Million |
MNBO
SAY
COUNCODOS
ATNM
FAG
SNMSF